News

  1. Home
  2. News

María José Alonso receives the ‘Honorific Award for Excellence in Scientific Research’ of the AstraZeneca Foundation

The Honorific Award has been awarded since 2017 to clinical researchers with a proven career in biomedical research and who have contributed to the generation of knowledge and advances in their specialty and to the training of new researchers.

Check out our latest paper, published in DDTR: ‘Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery’

In this work, we focused on an immunostimulant beta-glucan derivative, carboxymethyl-β-glucan, to prepare a novel nanocarrier in combination with chitosan.

Check out our OPEN ACESS publication: “A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin”

You will find out about a nanoemulsion that enables the encapsulation of hydrophobically modified insulin. The lesson learned is that with a simple modification of a macromolecule of interest, you can achieve great encapsulation values in a nanoemulsion, a protection against degradation and an increased permeability. Chemistry of the cargo is something to consider when designing new formulations.

Check out our OPEN ACESS publication: “Asymmetric flow field-flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers”

Check out our recent paper published OPEN ACCESS in Drug Delivery and Translational Research, and official journal of the Controlled Release Society (CRS). You will find out about the utility of Asymmetric flow field flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers.

Check out our OPEN ACESS article on “Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues”

Nanotechnology is now opening new avenues for the treatment of cancer. Here we present a critical view on the potential of nanotechnology to improve the delivery of drugs (small molecules, monoclonal antibodies and RNA-based therapies) to tumor cells or to the tumor microenvironment. We foresee a future where the therapeutic strategy can be thoughtfully designed taking into account the tumor type, the immune status of the patient, and the nature of the active molecule. This is the era of personalized nanomedicine.

María José Alonso receives the ‘Sanitarias 2021 Prize’, awarded by Redacción Médica

María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has been recognized with the Burdinola Research Award, which has highlighted her outstanding work in the field of personalized and regenerative biomedicine in relation to nanomaterials and nanoparticles.

Eleni Samaridou receives the Suárez Freire Prize for young researchers awarded by the Royal Academy of Pharmacy of Galicia

Our colleague Eleni Samaridou has just been recognized with the Julián Francisco Suárez Freire Prize for young researchers, awarded by the Royal Academy of Pharmacy of Galicia. Eleni Samaridou has received this award for a paper that describes a new nanotechnology which allows the delivery of microRNA (miRNA) from the nose directly to the brain, as a new therapeutic for Alzheimer's disease, which has been published in the prestigious journal Biomaterials in 2020.

María José Alonso enters the Royal Academy of Medicine of Belgium as a Foreign Member

María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has entered the Royal Academy of Medicine of Belgium (ARMB) as Foreign Member. This is a new recognition of the outstanding career of Professor Alonso by international scientific institutions.

María José Alonso receives the Burdinola Research Award

María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has been recognized with the Burdinola Research Award, which has highlighted her outstanding work in the field of personalized and regenerative biomedicine in relation to nanomaterials and nanoparticles.

María José Alonso, recognized with the Honorific Award for Excellence in Scientific Research of the AstraZeneca Foundation

The Honorific Award has been awarded since 2017 to clinical researchers with a proven career in biomedical research and who have contributed to the generation of knowledge and advances in their specialty and to the training of new researchers.